Missing Important Cancer Anniversaries and Grieving During COVID-19

January 27th 2021, 5:00pm

By Debbie Legault

COVID-19 has robbed us of the physical ways we remember important milestones on the cancer journey and the physical ways we need to mourn.

Certain Characteristics of Patients Receiving Treatment For Cancer-Related Pain Associated With Opioid Misuse

January 27th 2021, 4:00pm

By Brielle Benyon

Some patients receiving opioids to treat cancer-related pain may be more susceptible than others to engage in non-medical opioid use.

Chemotherapy With Immunotherapy Improves Overall Survival for Extensive-Stage Small Cell Lung Cancer

January 27th 2021, 2:00pm

By Darlene Dobkowski, MA

Tecentriq with carboplatin and etoposide led to a median overall survival rate of 12.3 months versus 10.3 months in those assigned placebo, carboplatin and etoposide, although the death rate was high at a median follow-up of 22.9 months.

What Do Patients With Cancer Wish Those Without the Disease Could Understand About Their Experiences?

January 26th 2021, 10:00pm

By Ryan McDonald

On social media, CURE® recently asked its readers to share what they wished people without cancer could understand about their experiences with the disease.

No One Ever Sees a Cancer Diagnosis Coming, Especially When it Involves Their Penis

January 26th 2021, 7:00pm

By Jonathan Little

A cancer survivor writes about how he, like many, was blindsided by his diagnosis and what it was like to receive treatment for a rare disease: penile cancer.

Embracing Our Sexy Self as Women After Surgery for Breast Cancer

January 26th 2021, 5:00pm

By Tamera Anderson-Hanna

Even after surgery for breast cancer women can still feel empowered and own their sense of self-worth.

Aspirin Use May Improve Survival in Bladder, Breast Cancer

January 26th 2021, 4:00pm

By Brielle Benyon

Regular aspirin use may increase survival in patients with bladder and breast cancer.

Nubeqa Improves 3-Year Survival in Nonmetastatic Prostate Cancer

January 26th 2021, 2:00pm

By Darlene Dobkowski, MA

At three years, overall survival in men with nonmetastatic, castration-resistant prostate cancer treated with Nubeqa was 83% compared with 77% in those who received placebo.

Recent Cancer Diagnosis Associated With Increased Risk of COVID-19, Especially in Black Patients

January 25th 2021, 10:00pm

By Colleen Moretti

People recently diagnosed with cancer may be at an increased risk of contracting COVID-19 and experiencing worse outcomes than those who have never had a cancer diagnosis. The association was heightened in Black patients.

National Organization Recommends COVID-19 Vaccine for Patients With Cancer

January 25th 2021, 7:00pm

By Brielle Benyon

The National Comprehensive Cancer Network (NCCN) recommends that patients receiving active cancer treatment get the COVID-19 vaccine.

How To Live In The Present As Cancer Survivors

January 25th 2021, 5:00pm

By Jane Biehl Ph.D.

A simple quote reminds a cancer survivor of what is important for every one of us to remember.

Opdivo Plus Yervoy Improves Survival for Patients with Rare Form of Eye Cancer

January 25th 2021, 4:00pm

By Colleen Moretti

Combination treatment with Opdivo and Yervoy may have better overall survival rates for patients with metastatic uveal melanoma.

Why It’s ‘Never Too Soon’ to Consider Clinical Trials as a Treatment Option

January 25th 2021, 2:00pm

By Jessica Skarzynski

Living With Pancreatic Cancer: a Patient and Provider Perspective

January 24th 2021, 3:00pm

By Kristie L. Kahl

On behalf of the National Pancreas Foundation, CURE spoke with Dr. Michael Goggin, from Johns Hopkins Medicine, and Tom Birsic, an executive board member since the organization’s inception, about living with pancreatic cancer.

How Image Visualization Complemented My Cancer Treatment

January 23rd 2021, 8:00pm

By Viney Kirpal

How the act of image visualization and mediation gave this cancer survivor a helpful complement to her cancer treatment.